<DOC>
	<DOC>NCT00063570</DOC>
	<brief_summary>The purpose of the study is to determine if the two drugs can help patients feel better while causing the tumor to become smaller or disappear; evaluate the safety of giving both pemetrexed and gemcitabine in patients with advanced breast cancer.</brief_summary>
	<brief_title>Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Must have received prior chemotherapy with Taxol (paclitaxel) or Taxotere (docetaxel). Less than 3 different chemotherapy treatments for metastatic disease. Prior treatment with hormonal and/or radiation therapy. Must have disease that can be measured. Must be able to take care of self needs for example personal hygiene Must not be pregnant or breastfeeding. Cancer that has spread to the brain. Treatment with Gemcitabine or Pemetrexed Unable to take folic acid or Vitamin B12 Treatment for another cancer within the last 5 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Cancer of Breast</keyword>
	<keyword>Cancer of the Breast</keyword>
</DOC>